Nektar Therapeutics (NKTR) Tops Q2 EPS by 4c

August 9, 2012 4:37 PM

Nektar Therapeutics (NASDAQ: NKTR) reported Q2 EPS of ($0.30), $0.04 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found